The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Druggability Indices for Protein Targets Derived from NMR-Based Screening Data
Abstract
An analysis of heteronuclear-NMR-based screening data is used to derive relationships between the ability of small molecules to bind to a protein and various parameters that describe the protein binding site. It is found that a simple model including terms for polar and apolar surface area, surface complexity, and pocket dimensions accurately predicts the experimental screening hit rates with an R(2) of 0.72, an adjusted R(2) of 0.65, and a leave-one-out Q(2) of 0.56. Application of the model to predict the druggability of protein targets not used in the training set correctly classified 94% of the proteins for which high-affinity, noncovalent, druglike leads have been reported. In addition to understanding the pocket characteristics that contribute to high-affinity binding, the relationships that have been defined allow for quantitative comparative analyses of protein binding sites for use in target assessment and validation, virtual ligand screening, and structure-based drug design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Numerical recipes: the art of scientific computing
Press, W. H., Flannery, B. P., Teukolsky, S. A., Vetterling, W. T., & Chipperfield, J. R. (1987) · Analytica Chimica Acta · doi:10.1016/s0003-2670(00)82860-3 · Cited by 3,304
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,041
Self-citationAnatomy of hot spots in protein interfaces
Bogan, A. A., & Thorn, K. S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1843 · Cited by 1,988
A simple physical model for binding energy hot spots in protein–protein complexes
Kortemme, T., & Baker, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202485799 · Cited by 804
Is There a Difference between Leads and Drugs? A Historical Perspective
Oprea, T. I., Davis, A. M., Teague, S. J., & Leeson, P. D. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010366a · Cited by 769
Unraveling hot spots in binding interfaces: progress and challenges
DeLano, W. L. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00283-x · Cited by 767
Fast prediction and visualization of protein binding pockets with PASS
Brady, G. P., & Stouten, P. F. W. (2000) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008124202956 · Cited by 531
Identification of Protein–Protein Interaction Sites from Docking Energy Landscapes
Fernández-Recio, J., Totrov, M., & Abagyan, R. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.069 · Cited by 274
Peters, K. P., Fauck, J., & Frömmel, C. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0077 · Cited by 243
Discovering High-Affinity Ligands for Proteins
Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1997) · Science · doi:10.1126/science.278.5337.497 · Cited by 236
Self-citationNMR-based screening in drug discovery
Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1999) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500003528 · Cited by 229
Self-citationAutomatic identification and representation of protein binding sites for molecular docking
Ruppert, J., Welch, W., & Jain, A. N. (1997) · Protein Science · doi:10.1002/pro.5560060302 · Cited by 207
Ligand binding: functional site location, similarity and docking
Campbell, S. J., Gold, N. D., Jackson, R. M., & Westhead, D. R. (2003) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(03)00075-7 · Cited by 199
NMR-Based Discovery of Lead Inhibitors That Block DNA Binding of the Human Papillomavirus E2 Protein
Hajduk, P. J., Dinges, J., Miknis, G. F., Merlock, M., Middleton, T., Kempf, D. J., Egan, D. A., Walter, K. A., Robins, T. S., Shuker, S. B., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9703404 · Cited by 168
Self-citationSearching for functional sites in protein structures
Jones, S., & Thornton, J. M. (2003) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2003.11.001 · Cited by 146
Wheatley, S. P., Henzing, A. J., Dodson, H., Khaled, W. T., & Earnshaw, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311299200 · Cited by 139
Sotriffer, C., & Klebe, G. (2002) · Il Farmaco · doi:10.1016/s0014-827x(02)01211-9 · Cited by 121
Experimental and computational mapping of the binding surface of a crystalline protein
English, A. C., Groom, C. R., & Hubbard, R. E. (2001) · Protein Engineering Design and Selection · doi:10.1093/protein/14.1.47 · Cited by 116
Structure-based screening of low-affinity compounds
Carr, R. A. E., & Jhoti, H. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02245-6 · Cited by 112
Organic solvents identify specific ligand binding sites on protein surfaces
Liepinsh, E., & Otting, G. (1997) · Nature Biotechnology · doi:10.1038/nbt0397-264 · Cited by 107
Protein surface roughness and small molecular binding sites 1 1Edited by F. Cohen
Pettit, F. K., & Bowie, J. U. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2411 · Cited by 93
Hajduk, P. J., Mack, J. C., Olejniczak, E. T., Park, C., Dandliker, P. J., & Beutel, B. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja039480v · Cited by 90
Self-citationLigand binding to domain-3 of human serum albumin: a chemometric analysis
Hajduk, P. J., Mendoza, R. R., Petros, A. M., Huth, J. R., Bures, M. G., Fesik, S. W., & Martin, Y. C. (2003) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1025305520585 · Cited by 50
Self-citation
Cited by
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
Scott, D. E., Bayly, A. R., Abell, C., & Skidmore, J. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.29 · Cited by 1,137
A decade of fragment-based drug design: strategic advances and lessons learned
Hajduk, P. J., & Greer, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2220 · Cited by 1,064
Self-citationTwenty years on: the impact of fragments on drug discovery
Erlanson, D. A., Fesik, S. W., Hubbard, R. E., Jahnke, W., & Jhoti, H. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.109 · Cited by 1,000
Self-citationStructure-based maximal affinity model predicts small-molecule druggability
Cheng, A. C., Coleman, R. G., Smyth, K. T., Cao, Q., Soulard, P., Caffrey, D. R., Salzberg, A. C., & Huang, E. S. (2007) · Nature Biotechnology · doi:10.1038/nbt1273 · Cited by 695
Metadata
- Authors
- Hajduk, P. J., Huth, J. R., & Fesik, S. W.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2005-02-24
- Volume
- 48
- Issue
- 7
- Pages
- 2518-2525
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1979598348
- Cited by
- 522
- References
- 23
- FWCI
- 30.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.